Insights into Adeno-Associated Virus Capsid Charge Heterogeneity
Open Access
- 17 July 2025
- journal article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (31) , 17132-17140
Abstract
A comprehensive workflow is described to examine three contributing factors to the charge heterogeneity of Adeno-associated viruses (AAVs) from a single sample. Intact AAV9 capsids were fractionated using imaged capillary isoelectric focusing (icIEF)-based fractionation, allowing for collection of capsids with different isoelectric points (pIs). Capsid integrity of the fractions was confirmed with analytical icIEF and charge detection mass spectrometry (CD-MS). Using capillary electrophoresis (CE) immunoassays, the capsid protein ratios and capsid protein deamidation were characterized. Additionally, to analyze ssDNA content packaged in each fraction, CE-immunoassay and high-resolution CD-MS were used. This study enhances our understanding of AAVs, by examining the contributions of its attributes to capsid charge heterogeneity.Keywords
This publication has 37 references indexed in Scilit:
- Enabling icIEF Peak Identification of AAV Capsid Proteins by Fractionation on MauriceFlex and Subsequent Analysis by LC–MSElectrophoresis, 2025
- Development of a highly sensitive imaged cIEF immunoassay for studying AAV capsid protein charge heterogeneityElectrophoresis, 2023
- Development of an icIEF assay for monitoring AAV capsid proteins and application to gene therapy productsMolecular Therapy - Methods & Clinical Development, 2023
- Fast and high-throughput LC-MS characterization, and peptide mapping of engineered AAV capsids using LC-MS/MSMolecular Therapy - Methods & Clinical Development, 2022
- Comparison of analytical techniques to quantitate the capsid content of adeno-associated viral vectorsMolecular Therapy - Methods & Clinical Development, 2021
- Quantitative analysis of genome packaging in recombinant AAV vectors by charge detection mass spectrometryMolecular Therapy - Methods & Clinical Development, 2021
- Analytical methods for process and product characterization of recombinant adeno-associated virus-based gene therapiesMolecular Therapy - Methods & Clinical Development, 2021
- Production, Processing, and Characterization of Synthetic AAV Gene Therapy VectorsBiotechnology Journal, 2020
- Adeno-Associated Virus (AAV) as a Vector for Gene TherapyBioDrugs, 2017
- Separation of adeno-associated virus type 2 empty particles from genome containing vectors by anion-exchange column chromatographyJournal of Virological Methods, 2007